Theravance Biopharma Inc (TBPH)
R&D Expenses
$4.71M
Quarterly · Period ending: · USD
TBPH R&D Expenses
Latest reported$4.71Mperiod ending
Latest reported$4.71Mperiod ending
TBPH Quarterly R&D Expenses ($26.09M → $4.71M)
Quarterly R&D Expenses
High-resolution chart · PNG
TBPH r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 4,712,000 | |
| 5,829,000 | |
| 6,963,000 | |
| 8,112,000 | |
| 10,490,000 | |
| 11,452,000 | |
| 9,375,000 | |
| 9,268,000 | |
| 9,954,000 | |
| 8,968,000 | |
| 8,995,000 | |
| 7,879,000 | |
| 11,372,000 | |
| 16,325,000 | |
| 17,294,000 | |
| 11,524,000 | |
| 16,466,999 | |
| 24,789,000 | |
| 33,130,000 | |
| 47,040,000 | |
| 52,353,000 | |
| 69,025,000 | |
| 69,447,000 | |
| 67,371,000 | |
| 62,404,000 | |
| 66,013,000 | |
| 67,025,000 | |
| 52,006,000 | |
| 46,399,000 | |
| 53,818,000 | |
| 52,269,000 | |
| 52,693,000 | |
| 48,621,000 | |
| 47,765,000 | |
| 51,051,000 | |
| 39,343,000 | |
| 42,927,000 | |
| 40,565,000 | |
| 42,013,000 | |
| 31,951,000 | |
| 32,069,000 | |
| 35,678,000 | |
| 32,402,000 | |
| 30,367,000 | |
| 30,377,000 | |
| 36,019,000 | |
| 42,192,000 | |
| 38,324,000 | |
| 46,283,000 | |
| 41,723,000 | |
| 32,470,000 | |
| 32,301,000 | |
| 30,400,000 | |
| 25,408,000 | |
| 28,136,000 | |
| 26,089,000 |